Ocular Drug Delivery Market


Sumitsaindane

Uploaded on Nov 28, 2023

The ocular drug delivery market trends include increase in prevalence of eye diseases, strong product pipeline, and surge in product approvals. The rise in prevalence of eye disorders is a major driving factor in the growth of the ocular drug delivery market.

Comments

                     

Ocular Drug Delivery Market

OCULAR DRUG DELIVERY MARKET By Technology (Topical, Ocular Insert, Intraocular Implants, In-Situ Gel, Others), By Formulation Type (Solution, Emulsion, Suspension, Ointment, Others), By Disease Indication (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Age related macular degeneration, Others), By End User (Hospitals, Ophthalmic Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032 P R I M E   D E T E R M I N A N T S   O F   G R O W T H • Request Free Download Sample:   https://www.alliedmarketresearc h.com/request-sample/3646   • Ocular drug delivery is the process of delivering drugs to the eyes in order to treat different types of eye disorders such as diabetic retinopathy, dry eye syndrome, age- related macular degeneration, and others. This specialized delivery system aims to minimize systemic side effects while optimizing the therapeutic effects of medications by addressing the limitations of the ocular environment. Ocular drug delivery systems are designed to improve the drug delivery and effectively provide medications to the intended tissues inside the eye. Ocular drug delivery involves the use of a variety of techniques, such as implants, ointments, eye drops, injections, and contact lenses. RECENT DEVE LOPMENTS IN  OCULAR DRUG Contact Lens Drug Delivery: Integration of drug delivery systems DELIVERY into contact lenses for controlled and sustained release of drugs, providing a MARKET  non-invasive and patient-friendly approach. Intravitreal Injections: Ongoing developments in intravitreal injection technologies, with a focus on minimizing discomfort, reducing injection frequency, and improving drug distribution within the eye. KEY PLAYERS: Santen Nocox Pharmace Novaliq utical Co., GmbH Ltd. Bausch Health Alimera Clearside Companies Sciences, Biomedical , Inc. Inc. , Inc. Kiora AbbVie Pharmace Ocular Inc. uticals, Therapeuti Inc. x, Inc. EyePoint Pharmace uticals, Inc. BY REGION: • North America  (U.S., Canada, Mexico) • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe) • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia- Pacific) • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA) CONTACT US: • David Correa  • 5933 NE Win Sivers Drive  • #205, Portland, OR 97220  • United States  • Toll-Free: 1-800-792-5285  • UK: +44-845-528-1300  • Hong Kong: +852-301-84916  • India (Pune): +91-20-66346060  • Fax: +1-855-550-5975  • [email protected]  • Web: https://www.alliedmarketresearch.com  • Follow Us on: LinkedIn Twitter THANK YOU !